Monster Beverage (NASDAQ:MNST – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.42 per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
Monster Beverage (NASDAQ:MNST – Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.04). The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Monster Beverage had a net margin of 22.84% and a return on equity of 22.23%. Monster Beverage’s quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.39 EPS. On average, analysts expect Monster Beverage to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Monster Beverage Price Performance
Shares of NASDAQ MNST opened at $54.11 on Wednesday. The business’s 50 day moving average price is $51.25 and its 200 day moving average price is $50.97. The firm has a market cap of $53.00 billion, a P/E ratio of 33.61, a P/E/G ratio of 2.37 and a beta of 0.74. Monster Beverage has a 52 week low of $43.32 and a 52 week high of $61.22. The company has a quick ratio of 2.69, a current ratio of 3.41 and a debt-to-equity ratio of 0.13.
Wall Street Analysts Forecast Growth
About Monster Beverage
Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally. The company operates through three segments: Monster Energy Drinks, Strategic Brands, Alcohol Brands, and Other.
See Also
- Five stocks we like better than Monster Beverage
- Stock Market Upgrades: What Are They?
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- 3 Warren Buffett Stocks to Buy Now
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?
Receive News & Ratings for Monster Beverage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monster Beverage and related companies with MarketBeat.com's FREE daily email newsletter.